Immunovant (IMVT) Interest & Investment Income (2019 - 2026)
Immunovant (IMVT) reported Interest & Investment Income of $8.1 million for Q1 2026, up 16.96% on a YoY basis from $6.9 million in Q1 2025, and up 51.06% quarter-over-quarter from $5.3 million in Q4 2025.
Immunovant (IMVT) Interest & Investment Income (2019 - 2026) Analysis & Trends
Immunovant has reported Interest & Investment Income for 5 years, with the latest figure at $8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 16.96% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $25.3 million (up 2.42% YoY), and the FY2026 full-year result was $25.3 million, up 2.42% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $8.1 million, up from $5.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $8.9 million in Q4 2023, with the low at $3.6 million in Q3 2023.
- Historically, Interest & Investment Income has averaged $6.3 million across 4 years, with a median of $6.2 million in 2024.
- The largest YoY upside for Interest & Investment Income was 76.63% in 2024 against a maximum downside of 48.62% in 2024.
- Immunovant's Interest & Investment Income stood at $8.9 million in 2023, then slumped by 48.62% to $4.6 million in 2024, then advanced by 16.19% to $5.3 million in 2025, then surged by 51.06% to $8.1 million in 2026.
- The last three Interest & Investment Income figures came in at $8.1 million (Q1 2026), $5.3 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Immunovant | 5.71 Bn | 5.71 Bn | - | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.06 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | 6.34 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 8.93 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Sep 30, 2019 | 683,140.00 |
| Jun 30, 2019 | 341,558.00 |